Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Chembiochem ; 23(17): e202200196, 2022 09 05.
Article in English | MEDLINE | ID: mdl-35762648

ABSTRACT

Targeting of glucagon-like peptide 1 receptor (GLP-1R), expressed on the surface of pancreatic ß-cells, is of great interest for the development of advanced therapies for diabetes and diagnostics for insulinoma. We report the conjugation of exendin-4 (Ex-4), an approved drug to treat type 2 diabetes, to poly-γ-glutamic acid (γ-PGA) to obtain more stable and effective GLP-1R ligands. Exendin-4 modified at Lysine-27 with PEG4-maleimide was conjugated to γ-PGA functionalized with furan, in different molar ratios, exploiting a chemoselective Diels-Alder cycloaddition. The γ-PGA presenting the highest number of conjugated Ex-4 molecules (average 120 per polymeric chain) showed a double affinity towards GLP-1R with respect to exendin per se, paving the way to improved therapeutic and diagnostic applications.


Subject(s)
Diabetes Mellitus, Type 2 , Pancreatic Neoplasms , Exenatide/chemistry , Glucagon-Like Peptide-1 Receptor , Glutamic Acid , Humans , Peptides/chemistry , Polyglutamic Acid/analogs & derivatives , Radiopharmaceuticals/chemistry
2.
Anticancer Res ; 39(5): 2415-2427, 2019 May.
Article in English | MEDLINE | ID: mdl-31092434

ABSTRACT

AIM: The purpose of this study was to develop a folate receptor-targeted 68Ga-labeled agent for the detection of cancer cells in mouse models of ovarian cancer by dual positron-emission tomography (PET) and magnetic resonance imaging (MRI). Moreover, we aimed to develop a controlled biopolymer-based chemistry that enables linking metal-binding (here Ga-68) chelators. MATERIALS AND METHODS: The nanoparticle (NP) agent was created by self-assembling of folic acid-modified polyglutamic acid and chelator-modified chitosan followed by radiolabeling with 68Ga (III) ions (68Ga-NODAGA-FA). The structure of modified biopolymers was characterized by spectroscopy. Particle size and mobility were determined. RESULTS: Significant selective binding of NPs was established in vitro using folate receptor-positive KB and - negative MDA-MB-231 cell lines. In vivo tumor uptake of folate-targeted 68Ga3+-radiolabeled NPs was tested using subcutaneous tumor-bearing CB17 SCID mice models. PET/MR dual modalities showed high tumor uptake with 6.5 tumor-to-muscle ratio and NP localization. CONCLUSION: In vivo results supporting the preliminary in vitro tests demonstrated considerably higher 68Ga-NODAGA-FA nanoparticle accumulation in KB tumors than in MDA-MB-231 tumors, thereby confirming the folate receptor-mediated uptake of this novel potential PET imaging agent.


Subject(s)
Folate Receptor 1/isolation & purification , Gallium Radioisotopes/chemistry , Nanoparticles/chemistry , Ovarian Neoplasms/diagnostic imaging , Acetates/chemistry , Animals , Chelating Agents/chemistry , Chitosan/chemical synthesis , Chitosan/chemistry , Chitosan/therapeutic use , Disease Models, Animal , Female , Folate Receptor 1/chemistry , Folic Acid/chemistry , Gallium Radioisotopes/therapeutic use , Heterocyclic Compounds, 1-Ring/chemistry , Humans , Magnetic Resonance Imaging/methods , Mice , Nanoparticles/therapeutic use , Ovarian Neoplasms/pathology , Polyglutamic Acid/chemistry , Positron-Emission Tomography/methods
3.
Int J Pharm ; 474(1-2): 91-4, 2014 Oct 20.
Article in English | MEDLINE | ID: mdl-25093694

ABSTRACT

A new biocompatible, biodegradable, self-assembled chitosan-based nanoparticulate product was successfully synthesized and radiolabeled with technetium-99m, and studied as a potential new SPECT or SPECT/CT imaging agent for diagnosis of folate receptor overexpressing tumors. In the present study we examined the conditions of a preclinical application of this labeled nanosystem in early diagnosis of spontaneously diseased veterinary patient using a human SPECT/CT device. The results confirmed that the nanoparticles accumulated in tumor cells overexpressing folate receptors, contrast agent revealed higher uptake in the tumor for a long time. Preclinical trials verified that the new nanoparticles are able to detect folate-receptor-overexpressing tumors in spontaneously diseased animal models with enhanced contrast.


Subject(s)
Chitosan/chemistry , Folate Receptors, GPI-Anchored/analysis , Folate Receptors, GPI-Anchored/metabolism , Nanoparticles/chemistry , Tomography, Emission-Computed, Single-Photon/methods , Tomography, X-Ray Computed/methods , Animals , Biocompatible Materials/chemical synthesis , Biocompatible Materials/chemistry , Cats , Chitosan/chemical synthesis , Female , Mouth Neoplasms/diagnosis , Mouth Neoplasms/metabolism , Multimodal Imaging/methods , Radiopharmaceuticals/chemical synthesis , Radiopharmaceuticals/chemistry
4.
Anticancer Res ; 34(1): 49-59, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24403444

ABSTRACT

AIM: The aim of this work was to synthesize and study in vitro and in vivo nanocarriers used as magnetic resonance imaging (MRI) contrast agents that accumulate in tumor cells specifically overexpressing folate receptors. MATERIALS AND METHODS: Nanoparticles were prepared by self-assembly of poly-γ-glutamic acid and chitosan biopolymers and were complexed with gadolinium ions. Folic acid served as a targeting molecule. Rat hepatocellular carcinoma (HeDe) cells overexpressing folate receptors were used as a model system. For in vivo experiments, HeDe cells were transplanted under the renal capsule of F344 rats. RESULTS: In vitro results showed the significant internalization of nanoparticles into HeDe cells. MRI measurements revealed that targeting nanocarriers accumulated in tumors. The MRI/PET fusion images resulted in the exact localization of tumors. CONCLUSION: The nanocarrier provides a suitable means for the early diagnosis of tumors based on their overexpression of folate receptors.


Subject(s)
Carcinoma, Hepatocellular/diagnosis , Liver Neoplasms/diagnosis , Magnetic Resonance Imaging , Nanoparticles , Positron-Emission Tomography , Animals , Carcinoma, Hepatocellular/metabolism , Cell Proliferation , Chitosan/metabolism , Contrast Media , Flow Cytometry , Folate Receptors, GPI-Anchored/metabolism , Folic Acid/metabolism , Liver Neoplasms/metabolism , Male , Polyglutamic Acid/analogs & derivatives , Polyglutamic Acid/metabolism , Radiopharmaceuticals , Rats , Rats, Inbred F344 , Tumor Cells, Cultured
5.
Int J Pharm ; 449(1-2): 10-7, 2013 Jun 05.
Article in English | MEDLINE | ID: mdl-23562750

ABSTRACT

We report the synthesis, in vitro and in vivo investigation of folate-targeted, biocompatible, biodegradable self-assembled nanoparticles radiolabelled with (99m)Tc, as potential new SPECT or SPECT/CT imaging agent. Nanoparticles with hydrodynamic size in the range of 75-200 nm were prepared by self-assembly of chitosan and folated poly-γ-glutamic acid, and then radiolabelled with (99m)Tc. The nanoparticles target tumour cells overexpressing folate receptors and internalize specifically into them to realize early tumour diagnosis detected by SPECT and SPECT/CT modalities. Rat hepatocellular carcinoma cells were used as model system. Cell specificity and tumour targeting efficacy of these nanosystems were investigated in vitro, and in vivo using SPECT and fusion nanoSPECT/CT imaging. In vitro results showed that the radiolabeled nanosystem was efficiently internalized by tumour cells. Whole-body biodistribution of the new radiolabelled, folate-targeted nanoparticles revealed higher uptake in the tumorous kidney compared to the non-tumorous contralateral side. Uptake by the lungs and thyroids was negligible, which confirmed the stability of the nanoparticles in vivo. In vivo SPECT and SPECT/CT imaging visually reinforced the uptake results and were in accordance with the biodistribution data: the new nanoparticles as a targeted contrast agent improve tumour targeting and are able to detect folate-receptor-overexpressing tumours in animal models with enhanced contrast.


Subject(s)
Carcinoma, Hepatocellular/diagnosis , Liver Neoplasms/diagnosis , Radiopharmaceuticals , Sodium Pertechnetate Tc 99m , Animals , Carcinoma, Hepatocellular/pathology , Chitosan/chemistry , Folate Receptors, GPI-Anchored/metabolism , Liver Neoplasms/pathology , Male , Nanoparticles , Particle Size , Radiopharmaceuticals/pharmacokinetics , Rats , Rats, Inbred F344 , Sodium Pertechnetate Tc 99m/pharmacokinetics , Tissue Distribution , Tomography, Emission-Computed, Single-Photon/methods , Tomography, X-Ray Computed/methods
6.
Int J Pharm ; 441(1-2): 234-41, 2013 Jan 30.
Article in English | MEDLINE | ID: mdl-23246780

ABSTRACT

We report here the synthesis, in vitro and in vivo investigation of magnetic resonance imaging (MRI) active nanoparticles, which target folate receptor overexpressing tumor cells. Self-assembled nanoparticles with a hydrodynamic size of 50-200 nm were prepared from poly-γ-glutamic acid and chitosan biopolymers with Gd-ions. The nanoparticles are biocompatible, non-toxic and stable for several months in aqueous media. In vitro assays using confocal microscopy, flow cytometry and MR imaging on HeLa human cervix carcinoma tumor cells showed that folic acid targeted nanoparticles were internalized specifically in a folate receptor dependent manner. In vivo study confirmed, that, considerable accumulation of nanosystems was found compared with the control animal represented by the MR images. Relaxometry measurements demonstrated that the nanoparticle-Gd complexes drastically change the signal intensity of the tumor cells. Because of the contrast enhancement, they are attractive candidates as potential contrast agents for a variety of diagnostic applications including early diagnosis of tumors.


Subject(s)
Gadolinium , Magnetic Resonance Imaging/methods , Nanoparticles , Uterine Cervical Neoplasms/diagnosis , Animals , Chitosan/chemistry , Contrast Media/administration & dosage , Drug Stability , Drug Storage , Female , Flow Cytometry , Folate Receptors, GPI-Anchored/metabolism , Folic Acid/administration & dosage , Folic Acid/chemistry , Gadolinium/administration & dosage , HeLa Cells , Humans , Mice , Mice, Nude , Microscopy, Confocal , Particle Size , Polyglutamic Acid/analogs & derivatives , Polyglutamic Acid/chemistry , Time Factors , Xenograft Model Antitumor Assays
7.
J Hazard Mater ; 153(3): 1185-92, 2008 May 30.
Article in English | MEDLINE | ID: mdl-17997032

ABSTRACT

The present investigation describes the preparation and characterization of novel biodegradable nanoparticles based on complexation of poly-gamma-glutamic acid (gamma-PGA) with bivalent lead ion. The prepared nano-systems were stable in aqueous media at low pH, neutral and mild alkaline conditions. The particle size and the size of the complexes were identified by dynamic light scattering (DLS) and transmission electron microscopy (TEM) measurements. It was found that the size of the complexes depended on the pH and concentrations of gamma-PGA and lead ions. Particle sizes measured by TEM revealed that at low concentrations, nanosized particles were formed, however, at high concentrations of gamma-PGA and lead ions, the formation of large aggregates with a broad size distribution was promoted. The size of individual particles was in the range of 40-100 nm measured by TEM. The results from the DLS measurements showed that the low and high pH values in mixtures with high concentrations of gamma-PGA and Pb2+ ions favored the growth of large complexes. The gamma-PGA nanoparticles, composed of a biodegradable biomaterial with high flocculating and heavy metal binding activity, may be useful for various water treatment applications.


Subject(s)
Lead/chemistry , Nanoparticles/chemistry , Polyglutamic Acid/analogs & derivatives , Waste Disposal, Fluid/methods , Water Purification/methods , Flocculation , Hydrogen-Ion Concentration , Microscopy, Electron, Transmission , Nanoparticles/ultrastructure , Nephelometry and Turbidimetry , Particle Size , Polyglutamic Acid/chemistry
8.
Biomacromolecules ; 7(11): 3030-6, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17096528

ABSTRACT

The present investigation describes the synthesis and characterization of novel biodegradable nanoparticles based on chitosan. Poly(ethylene glycol) dicarboxylic acid was used for intramolecular cross-linking of the chitosan linear chains. The condensation reaction of carboxylic groups and pendant amino groups of chitosan was performed by using water-soluble carbodiimide. The prepared nanosystems were stable in aqueous media. The structure of the products was determined by nuclear magnetic resonance (NMR) spectroscopy, and the particle size was identified by dynamic light scattering (DLS) and transmission electron microscopy (TEM) measurements. It was found that biodegradable cross-linked chitosan nanoparticles experienced considerable swelling because of the length and flexibility of the cross-linking agent. The aqueous solutions or dispersions of nanoparticles were stable and clear or mildly opalescent systems depending on the ratio of cross-linking and molecular weight of chitosan, findings consistent with values of transmittance above 75%. Particle size measured by TEM varied in the range of 4-24 nm. In the swollen state, the average size of the individual particles measured by DLS was in the range of 50-120 nm depending on the molecular weight of chitosan and the ratio of cross-linking.


Subject(s)
Chitosan/chemistry , Nanoparticles , Polyethylene Glycols/chemistry , Magnetic Resonance Spectroscopy , Microscopy, Electron, Transmission , Molecular Weight , Particle Size , Solubility
9.
Biomacromolecules ; 6(5): 2521-7, 2005.
Article in English | MEDLINE | ID: mdl-16153088

ABSTRACT

The present investigation describes the synthesis and characterization of novel biodegradable nanoparticles based on chitosan for biomedical applications. Natural di- and tricarboxylic acids were used for intramolecular cross-linking of the chitosan linear chains. The condensation reaction of carboxylic groups and pendant amino groups of chitosan was performed by using water-soluble carbodiimide. This method allows the formation of polycations, polyanions, and polyampholyte nanoparticles. The prepared nanosystems were stable in aqueous media at low pH, neutral, and mild alkaline conditions. The structure of products was determined by NMR spectroscopy, and the particle size was identified by laser light scattering (DLS) and transmission electron microscopy (TEM) measurements. It was found that particle size depends on the pH, but at a given pH, it was independent of the ratio of cross-linking and the cross-linking agent. Particle size measured by TEM varied in the range 60-280 nm. In the swollen state, the average size of the particles measured by DLS was in the range 270-370 nm depending on the pH. The biodegradable cross-linked chitosan nanoparticles, as solutions or dispersions in aqueous media, might be useful for various biomedical applications.


Subject(s)
Chitosan/chemistry , Nanostructures/chemistry , Biocompatible Materials , Biodegradation, Environmental , Biotechnology/methods , Buffers , Carbodiimides/chemistry , Chitin/chemistry , Chitosan/chemical synthesis , Citric Acid/pharmacology , Cross-Linking Reagents/chemistry , Cross-Linking Reagents/pharmacology , Drug Carriers , Hydrogen-Ion Concentration , Light , Magnetic Resonance Spectroscopy , Malates/pharmacology , Microscopy, Electron, Transmission , Models, Chemical , Molecular Weight , Nanotechnology , Particle Size , Polyamines/chemistry , Polyelectrolytes , Polymers/chemistry , Scattering, Radiation , Tartrates/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...